These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 30593761)
1. Clinical significance of serum caveolin-1 levels in gastric cancer patients. Tas F; Karabulut S; Erturk K; Duranyildiz D Exp Oncol; 2018 Dec; 40(4):323-327. PubMed ID: 30593761 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum leptin level in patients with gastric cancer. Tas F; Karabulut S; Erturk K; Duranyildiz D Eur Cytokine Netw; 2018 Jun; 29(2):52-58. PubMed ID: 30078770 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum caveolin-1 levels in melanoma patients. Tas F; Karabulut S; Tilgen Yasasever C; Duranyildiz D Int J Dermatol; 2016 May; 55(5):558-62. PubMed ID: 26084616 [TBL] [Abstract][Full Text] [Related]
4. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer. Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430 [TBL] [Abstract][Full Text] [Related]
5. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables. Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer. Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D Biomed Pharmacother; 2015 Mar; 70():19-23. PubMed ID: 25776473 [TBL] [Abstract][Full Text] [Related]
7. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer. Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer. Kim JH; Jun KH; Jung H; Park IS; Chin HM Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088 [TBL] [Abstract][Full Text] [Related]
9. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment. Li F; Li S; Wei L; Liang X; Zhang H; Liu J Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812 [TBL] [Abstract][Full Text] [Related]
10. Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis. Hirahara N; Tajima Y; Fujii Y; Kaji S; Yamamoto T; Hyakudomi R; Taniura T; Kawabata Y BMC Cancer; 2018 Mar; 18(1):285. PubMed ID: 29534689 [TBL] [Abstract][Full Text] [Related]
11. The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy. Chen S; Feng XY; Li YF; Zhao BW; Zhou ZW; Chen YB J Surg Oncol; 2013 May; 107(6):641-5. PubMed ID: 23297055 [TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients. Tas F; Bilgin E; Tastekin D; Erturk K; Duranyildiz D J Gastrointest Cancer; 2016 Jun; 47(2):182-6. PubMed ID: 27038444 [TBL] [Abstract][Full Text] [Related]
13. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer. Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496 [TBL] [Abstract][Full Text] [Related]
14. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers? Erturk K; Tastekin D; Bilgin E; Serilmez M; Bozbey HU; Sakar B Biomed Pharmacother; 2016 Feb; 77():86-91. PubMed ID: 26796270 [TBL] [Abstract][Full Text] [Related]
15. Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment. Kefeli U; Yildirim ME; Aydin D; Madenci OC; Yasar N; Sener N; Mert AG; Yuksel S; Ercelep OB; Korkmaz T; Yildiz R; Gumus M Biomarkers; 2012 Nov; 17(7):663-7. PubMed ID: 22889408 [TBL] [Abstract][Full Text] [Related]
16. Serum interleukin-6 levels reflect disease status of gastric cancer. Wu CW; Wang SR; Chao MF; Wu TC; Lui WY; P'eng FK; Chi CW Am J Gastroenterol; 1996 Jul; 91(7):1417-22. PubMed ID: 8678006 [TBL] [Abstract][Full Text] [Related]
17. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study. Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164 [TBL] [Abstract][Full Text] [Related]
18. High level of serum AFP is an independent negative prognostic factor in gastric cancer. Chen Y; Qu H; Jian M; Sun G; He Q Int J Biol Markers; 2015 Nov; 30(4):e387-93. PubMed ID: 26349668 [TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. Sun Z; Zhang N World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664 [TBL] [Abstract][Full Text] [Related]
20. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer. Tas F; Karabulut S; Serilmez M; Karabulut M; Duranyildiz D Cancer Chemother Pharmacol; 2016 Jan; 77(1):127-31. PubMed ID: 26499899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]